A PYMNTS Company

Turkey’s Competition Watchdog Fines Novartis & Roche

By  |  January 24, 2021

Turkey’s Competition Board announced on Friday, January 22, it imposed fines on Turkish units of pharmaceutical companies Novartis and Roche for trying to popularize a more expensive medicine used for eye diseases at the expense of a cheaper one.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Novartis was fined 165.46 million lira (US$22.35 million), while Roche was fined 112.97 million lira (US$15.22 million), the board stated.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.